Task: Please answer the following question about the molecule with SMILES CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.
Description: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.